April 1, 2019 – UC San Diego Altman Clinical and Translational Research Institute (ACTRI) and Pfizer's Center for Therapeutic Innovation (CTI) are seeking pre-proposals from UC San Diego Health Sciences faculty interested in a drug discovery collaboration with the Pfizer CTI. Proposals are sought for therapeutic targets.
UC CAI Webinar: Accelerating Translation of Academic Drug Development
The University of California Center for Accelerated Innovation (UC CAI) is hosting a webinar, “Accelerating Translation of Academic Drug Development,” on Tuesday, January 8, 2019, from 1 p.m. to 2 p.m. PDT. The webinar is being presented by the Harrington Discovery Institute, an international initiative that helps translate scientific discoveries into medicines that benefit our society. RSVP is not required.
View the pdf for more information.
UC CAI includes UC San Diego, UCSF, UCLA, UC Irvine, and UC Davis, and is supported by the National Heart, Lung, and Blood Institute (NHLBI) and the National Institute on Drug Abuse (NIDA) through grant 1U54HL119893.